14638885

Source:http://linkedlifedata.com/resource/pubmed/id/14638885

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0015672, umls-concept:C0034261, umls-concept:C0080040, umls-concept:C0205245, umls-concept:C0439801
pubmed:issue	12
pubmed:dateCreated	2003-11-25
pubmed:abstractText	To investigate the effect of pyridostigmine on fatigue, physical performance, and muscle function in subjects with postpoliomyelitis syndrome.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-10025486, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-10522877, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-10644779, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-10994028, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-11591066, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-11870712, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-1312674, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-1324424, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-1371741, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-1758789, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-1953324, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-1991011, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-2166138, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-2385251, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-2803071, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-3016197, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-3315237, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-3398882, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-3587319, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-3867865, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-6273721, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-7611623, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-7611626, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-7922455, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-7944918, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-8332669, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-8383188, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-8529175, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-8845722, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-9543741, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-9685105, http://linkedlifedata.com/resource/pubmed/commentcorrection/14638885-9771666
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985191R
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Pyridostigmine Bromide
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0022-3050
pubmed:author	pubmed-author:BeeleyLL, pubmed-author:BussmannJ B JJB, pubmed-author:DrostGG, pubmed-author:HoremansH L DHL, pubmed-author:LankhorstG JGJ, pubmed-author:NolletFF, pubmed-author:StegemanD FDF, pubmed-author:ZwartsM JMJ, pubmed-author:de VisserMM
pubmed:issnType	Print
pubmed:volume	74
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1655-61
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:14638885-Adult, pubmed-meshheading:14638885-Cholinesterase Inhibitors, pubmed-meshheading:14638885-Double-Blind Method, pubmed-meshheading:14638885-Exercise Tolerance, pubmed-meshheading:14638885-Female, pubmed-meshheading:14638885-Follow-Up Studies, pubmed-meshheading:14638885-Humans, pubmed-meshheading:14638885-Male, pubmed-meshheading:14638885-Middle Aged, pubmed-meshheading:14638885-Muscle Fatigue, pubmed-meshheading:14638885-Postpoliomyelitis Syndrome, pubmed-meshheading:14638885-Psychomotor Performance, pubmed-meshheading:14638885-Pyridostigmine Bromide, pubmed-meshheading:14638885-Severity of Illness Index, pubmed-meshheading:14638885-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement.
pubmed:affiliation	Department of Rehabilitation Medicine, VU University Medical Centre, Amsterdam, Netherlands. h.horemans@vumc.nl
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't